In good agreement with our findings, a study that investigated the expression of some EMT markers during breast cancer progression also demonstrated vimentin expression positivity associated with aggressive tumors such as the triple-negative subtype [37].
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614906/
